Literature DB >> 18563173

A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia.

M P Martelli, N Manes, A Liso, V Pettirossi, B Verducci Galletti, B Bigerna, A Pucciarini, M F De Marco, M T Pallotta, N Bolli, M Sborgia, F di Raimondo, F Fabbiano, G Meloni, G Specchia, M F Martelli, B Falini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18563173     DOI： 10.1038/leu.2008.149

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  Molecular and alternative methods for diagnosis of acute myeloid leukemia with mutated NPM1: flexibility may help.

Authors:  Brunangelo Falini; Maria Paola Martelli; Stefano A Pileri; Cristina Mecucci
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

2.  A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis.

Authors:  Carolien M Woolthuis; André B Mulder; Rikst Nynke Verkaik-Schakel; Stefano Rosati; Arjan Diepstra; Eva van den Berg; Jan Jacob Schuringa; Edo Vellenga; Philip M Kluin; Gerwin Huls
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

3.  Mutant NPM1 Maintains the Leukemic State through HOX Expression.

Authors:  Lorenzo Brunetti; Michael C Gundry; Daniele Sorcini; Anna G Guzman; Yung-Hsin Huang; Raghav Ramabadran; Ilaria Gionfriddo; Federica Mezzasoma; Francesca Milano; Behnam Nabet; Dennis L Buckley; Steven M Kornblau; Charles Y Lin; Paolo Sportoletti; Maria Paola Martelli; Brunangelo Falini; Margaret A Goodell
Journal:  Cancer Cell       Date:  2018-09-10       Impact factor: 31.743

4.  Bone Marrow Clonogenic Myeloid Progenitors from NPM1-Mutated AML Patients Do Not Harbor the NPM1 Mutation: Implication for the Cell-Of-Origin of NPM1+ AML.

Authors:  Rafael Diaz de la Guardia; Laura González-Silva; Belén López-Millán; Juan José Rodríguez-Sevilla; Matteo L Baroni; Clara Bueno; Eduardo Anguita; Susana Vives; Laura Palomo; Helene Lapillonne; Ignacio Varela; Pablo Menendez
Journal:  Genes (Basel)       Date:  2020-01-09       Impact factor: 4.096

5.  CD123 Is Consistently Expressed on NPM1-Mutated AML Cells.

Authors:  Vincenzo Maria Perriello; Ilaria Gionfriddo; Roberta Rossi; Francesca Milano; Federica Mezzasoma; Andrea Marra; Orietta Spinelli; Alessandro Rambaldi; Ombretta Annibali; Giuseppe Avvisati; Francesco Di Raimondo; Stefano Ascani; Brunangelo Falini; Maria Paola Martelli; Lorenzo Brunetti
Journal:  Cancers (Basel)       Date:  2021-01-28       Impact factor: 6.639

6.  A Curious Novel Combination of Nucleophosmin (NPM1) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of NPM1 in Acute Myeloid Leukemia (AML).

Authors:  Alessandra Venanzi; Roberta Rossi; Giovanni Martino; Ombretta Annibali; Giuseppe Avvisati; Maria Grazia Mameli; Paolo Sportoletti; Enrico Tiacci; Brunangelo Falini; Maria Paola Martelli
Journal:  Genes (Basel)       Date:  2021-09-16       Impact factor: 4.096

7.  Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML.

Authors:  Maria Paola Martelli; Roberta Rossi; Alessandra Venanzi; Manja Meggendorfer; Vincenzo Maria Perriello; Giovanni Martino; Orietta Spinelli; Raffaella Ciurnelli; Emanuela Varasano; Lorenzo Brunetti; Stefano Ascani; Corinne Quadalti; Valeria Cardinali; Federica Mezzasoma; Ilaria Gionfriddo; Francesca Milano; Roberta Pacini; Alessia Tabarrini; Barbara Bigerna; Francesco Albano; Giorgina Specchia; Calogero Vetro; Francesco Di Raimondo; Ombretta Annibali; Giuseppe Avvisati; Alessandro Rambaldi; Franca Falzetti; Enrico Tiacci; Paolo Sportoletti; Torsten Haferlach; Claudia Haferlach; Brunangelo Falini
Journal:  Blood       Date:  2021-12-23       Impact factor: 25.476
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.